Training Programs in Vascular Biology
Heart Institute NIH T32 Funded Training Program for Postdoctoral Research - Cedars-Sinai Medical Center
Eduardo Marbán, M.D., Ph.D.
Mark Siegel Family Foundation Distinguished Chair and Director of the Heart Institute
Director, Cedars-Sinai Smidt Heart Institute
Professor of Medicine and Physiology
Joshua I. Goldhaber, M.D.
Dorothy and E. Phillip Lyon Chair in Laser Research
Director, Basic Research Programs
Director, Cardiology Fellowship Program
Associate Director, Cardiac Intensive Care Unit
Director, Division of Applied Cell Biology & Physiology
Professor of Medicine
Program Scope and Mission – The objective of The Cedars-Sinai Smidt Heart Institute Institutional Training Program is to provide postdoctoral fellows with the necessary skills to develop independent and productive academic careers in cardiovascular science. We seek to ensure that all our trainees, be they PhDs, MDs, MD/PhDs or equivalent, develop an in-depth knowledge of the basic science underpinning clinically relevant problems in cardiovascular medicine, as well as a comprehensive understanding of rigorous study design, appropriate methodology and expert technical execution of basic and clinical studies. This not only provides clinical investigators with the skills they need to properly test hypotheses generated at the basic science level, but also informs basic scientists about the clinical aspects of disease in order to stimulate clinically relevant state-of-the-art investigations in the laboratory.Our training program’s areas of research focus include Cardiac Biology, Arrhythmias, Vascular Biology and Atherosclerosis, Regenerative Medicine, Transplant Immunology, Cardiovascular Imaging, Women’s Health, Community Health, Implementation Science, Precision Medicine and Genetics. The Training Program takes full advantage of the unique strengths of Cedars-Sinai Medical Center (CSMC), the largest private teaching hospital west of the Mississippi, which has a longstanding commitment to translational research and to serving the local community. The Cedar Sinai Heart Institute (CSHI) houses the largest adult heart transplant program in the world, performed an NIH-funded first-in-human trial of cardiac-derived stem cell therapy, and has attracted many NIH-funded basic and translational investigators. Some of these share joint appointments in other CSMC units, which include the Regenerative Medicine Institute, Biomedical Imaging Research Institute, and the Departments of Biomedical Sciences, Medicine, and Pathology. Trainees receive an intensive research experience in a focused area of investigation, augmented by a formal curriculum that includes both basic and clinical seminars, instruction in grant and manuscript writing, public speaking, biostatistics and ethics. Several courses are provided by the Department of Biomedical Sciences, the CSMC Clinical Scholars Program, and a multi-campus NIH CTSA-supported Center for Translational Science Institute (CTSI, includes CSMC, UCLA, Harbor-UCLA, and Charles Drew University). The CTSI provides our trainees with privileged access to project seed funds, additional courses in clinical research design, and tools for conducting the entire range of studies from bench to bedside to community. In summary, we have designed a program that provides in-depth training in critical areas of cardiovascular science within an environment that champions translational research and clinical excellence.
Training In Translational Science & Cardiovascular Medicine - Oregon Health & Science University
Nabil J. Alkayed, MD, PhD
James Metcalfe Chair of Cardiovascular Medicine
Professor and Director of Research, Knight Cardiovascular Institute
Oregon Health & Science University
3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239
Mail Code: UHN-2 ; Phone: 503.418.5502
Program Scope and Mission – http://www.navbo.info/OHSU2017-18.pdf.
Research Fellowship Program in Cardiovascular Disease Prevention- Stanford Prevention Research Center
Christopher Gardner, PhD
Alana Koehler, Fellowship Coordinator
Administrative Associate for Christopher Gardner, PhD
Stanford Prevention Research Center
1265 Welch Road, X3C06
Stanford, CA 94305-5411
Voice 650 723 7822
Fax 650 725 6247
Program Scope and Mission Postdoctoral Research Fellowship in Chronic Disease Prevention and Control. The Stanford Prevention Research Center, an interdisciplinary research program on the prevention of chronic disease, is seeking MD and PhD applicants for postdoctoral research fellowships for the academic year 2018-2019. Fellows gain direct research experience in cardiovascular disease prevention, community and health psychology, behavioral medicine, intervention methods, clinical epidemiology, research design, and biostatistics.See also the website for additional details http://prevention.stanford.edu/education/fellowship/training.html
Mechanisms and Innovation in Vascular Disease – Stanford University CVI
Ronald Dalman, M.D.
Chidester Professor of Surgery
David L. M. Preston, M.A.
Cardiovascular Institute Program Manager
265 Campus Drive, G1120; MC-5454
Stanford, CA 94305
Program Scope and Mission - This program trains a total of six fellows over two years in the following areas of vascular medicine & research: Vascular Reactivity & Thrombosis, Vascular Regeneration & Development, Metabolic or Lifestyle Influences on Vascular Outcomes, Proteomic Markers & Genetic Determinants of Vascular Disease, Gender & Ethnicity Differences in Vascular Disease, and Vascular Bioengineering. Twenty-nine faculty mentors from eighteen different departments within the School of Medicine and the University provide a variety of angles from which to address fundamental questions about vascular disease. A structured curriculum, well-defined mentorship, and both internal and external evaluations ensure that fellows receive training in both research and career development to prepare them for independent careers. All fellows undergo a minimum two-year training period, with strong encouragement to submit individual research proposals (NRSA and AHA) for the following year(s). Support for a second year is conditional on evidence of research progress. At times a third year is offered for the transition to independence. It is mandatory that in Year 1 the trainee and mentor will outline a career plan for transition to independence, which may include grant preparations for funding through a K08 mechanism or application to the existing K12.
Multi-Disciplinary Training Program in Cardiovascular Imaging - Stanford University School of Medicine
Joseph Wu, MD, PhD
Stanford University School of Medicine
ProfessorDirector, Stanford Cardiovascular Institute
Simon H. Stertzer, MD Professor of Medicine & Radiology
Lorry I. Lokey Stem Cell Research Building
265 Campus Drive, Rm G1120B
Stanford, CA 94305-5454
CVI Website: http://med.stanford.edu/cvi.html
Program Scope and Mission – The Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford is funded by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health. The program is designed to train the next generation of CV imaging investigators by exposing them to three complementary areas – clinical, engineering, and molecular imaging. With the impact of cardiovascular disease on US and world health and the rapid advances in imaging technologies and cardiovascular biology, it is critical that fellows be provided a broad, multi-disciplinary, and collaborative training program to foster their ability to translate CV imaging research into clinical application. Mentors from the Schools of Medicine and Engineering, including Cardiovascular Medicine, Radiology, Molecular Imaging, Electrical Engineering, and Bioengineering are available. For more details: http://med.stanford.edu/cvi/education/cardiovascular-imaging-t32.html
Cardiovascular Biomedical Engineering Training Grant, Pre-doctoral Training – University of Arizona
Jennifer K. Barton, Ph.D.
Director, BIO5 Institute
Professor, Biomedical Engineering
Professor, Optical Sciences
Professor, Agricultural-Biosystems Engineering
Professor, BIO5 Institute
Dr. Jennifer K. Barton
Program Scope and Mission – The Cardiovascular Biomedical Engineering training program is dedicated to training pre-doctoral students in both biological and engineering disciplines focusing on cardiovascular health to meet the demands of a growing biomedical engineering field.This program takes advantage of the UA Department of Biomedical Engineering faculty's, and the Arizona industrial community's strong expertise in bioengineering and cardiovascular biology. Areas of expertise include biomechanics, biomaterials, optics, molecular genetics, vascular physiology, imaging, tissue engineering, genetic engineering and biocomputing.
Vascular Biology Training Program - University of California, Los Angeles
Luisa Iruela-Arispe, PhD
Professor and Vice-Chair, Dept. of Molecular, Cell & Developmental Biology
Director, Molecular Biology Institute
Chair, Molecular Biology IDP
610 Charles E. Young Drive East
Los Angeles, CA 90095-7239
610 Charles E. Young Drive East
Los Angeles, CA 90095-7239
Phone: (310) 983-1283
Program Scope and Mission - The main objective of the Vascular Biology Training Program is to develop the next generation of cardiovascular biologists. The program places a strong emphasis on creativity, networking and self-motivation to develop independent scientists who will make significant contributions to biomedical research and be an asset to the institutions and communities they serve.To achieve these goals, we have developed a strong mentorship approach, novel didactic components and incorporated high exposure to medicine. UCLA houses a tremendous resource of interdisciplinary groups whose research focuses in vascular biology. The group includes 27 laboratories that currently offer training to 124 graduate students and postdoctoral fellows. It is this community that constitutes the pillars of a unique training program for the next generation of investigators in this area of research. The Program is funded by a grant from the NHLBI that supports pre- and post-doctoral trainees for three and two years respectively. The program also features a highly interactive seminar series with outside speakers and several seminar venues for discussion of science by trainees and UCLA investigators. We invite you to drive through the website and get to learn more about our program and recent accomplishments.
Integrated Fellowship on the Epidemiology and Prevention of Cardiovascular Diseases - University of California, San Diego
Matthew A. Allison, MD, MPH, FAHA
University of California San Diego
Professor and Interim Chief
Division of Preventive Medicine
Department of Family Medicine and Public Health
9500 Gilman Drive, Mailcode 0965
La Jolla, CA 92093-0965
Nova Barkley, T32 coordinator
9500 Gillman Drive, MC 0607
La Jolla, CA 92093-0607
Program Scope and Mission – http://cvdepit32.ucsd.edu.
Training in Integrative Bioengineering of Heart, Vessels, and Blood (T32 HL 105373) - University of California, San Diego
Director and Contact:
Andrew D. McCulloch, Ph.D.
UC San Diego
Department of Bioengineering
9500 Gilman Ave. MC0412
La Jolla, CA 92093-0412
Program Scope and Mission – The aim of this program is to train pre-doctoral bioengineering graduate students to apply quantitative bioengineering approaches to study integrative cardiac, vascular and blood physiology and pathophysiology and to work with physicians on developing novel technologies for therapy and diagnosis of cardiovascular diseases. Trainees learn how to conduct interdisciplinary research by integrating: (a) the engineering and biomedical sciences; (b) across physical scales of biological structure from genes and molecules to tissues and organ-systems; (c) across interacting physiological systems and subsystems; and (d) basic research with technology innovation for clinical applications. Our goal is to train the next generation of bioengineering scientists to be leaders in innovative cardiovascular research and technology development to advance healthcare delivery and improve health outcomes. The program is especially well known for its leadership in systems biology, regenerative medicine and multi-scale bioengineering. Graduates have gone on to become leaders in research, industry and academia including department chairs of top programs.
Research Fellowship in Blood Cells in Hemostasis and Thrombosis – UC San Diego School of Medicine
Mark Howard Ginsberg, M.D.
Distinguished Professor, School of Medicine
9500 Gilman Drive, MC0726
La Jolla, CA 92093
Program Scope and Mission – Arterial thrombosis is frequently the proximate cause of death and morbidity in cardiovascular diseases. These diseases are the leading cause of death in the Western World. Formed elements of the blood and cells of the vessel wall play central roles in arterial thrombosis and in the arrest of bleeding. We have begun an interdisciplinary training program for postdoctoral scientists in the area of blood cells in hemostasis and thrombosis, based in the Division of Hematology-Oncology, to be a centerpiece in an Initiative in Vascular Biology at the University of California San Diego, La Jolla Campus.Each faculty mentor is an internationally recognized investigator in the development and functioning of the cells that mediate thrombosis and has a strong track record of peer-reviewed research support and of training. The faculty has interacted extensively through the mechanisms of collaboration and through two program projects focused on Vascular Biology and Hemostasis-thrombosis. The interdisciplinary nature of the program is established by faculty primary appointments in six University departments including Cellular and Molecular Medicine, Biology, Pathology, Pharmacology, Physics and Medicine. The core of the program is through performance research in faculty laboratories spanning the disciplines of signal transduction, gene regulation, hematopoiesis, angiogenesis, and the molecular and cell biology of cells of the blood and vessel wall. The practical training will be complemented by didactic coursework in the conduct of research and in the writing of scientific manuscripts and grant applications. Furthermore, the trainees will attend a weekly conference in Atherosclerosis, Thrombosis, and Vascular Biology and will have the opportunity to participate in didactic hematology-oncology translational research conferences and in elective coursework offered throughout UC San Diego. This training program provides a unique interdisciplinary educational opportunity to mentor outstanding scientists for research careers in the cellular basis of hemostasis and thrombosis and will form the only active training program at UC San Diego directly devoted to this health-related field.
Biomedical Sciences Graduate Program - University of California San Francisco
K. Mark Ansel, PhD
K. Mark Ansel, Ph.D.
Associate Professor, UCSF Department of Microbiology and Immunology
Investigator, Sandler Asthma Basic Research Center
Director, Biomedical Sciences Graduate Program
513 Parnassus Avenue, Box 0414, HSE-1001E
San Francisco, CA 94143-0414
Office: (415) 476-5368
Lab: (415) 476-5373
Fax: (415) 502-4995
Program Scope and Mission The Biomedical Sciences (BMS) Graduate Program at UCSF provides students with a wide range of opportunities for their development as researchers that investigate the function of tissue and organ systems in development, physiology and disease. The BMS program’s curriculum provides a foundation in molecular biology, biochemistry, cell biology and the investigation of human biology and disease, and is customized to thematic areas through innovative mini-courses, research rotations, thematic retreats, seminars and other events. Vascular & Cardiac Biology is one of the BMS program's major themes, with over 25 dedicated faculty that are world renowned experts in their respective fields. The program provides in depth interaction and access to the Cardiovascular Institute (CVRI) and the Gladstone Institute of Cardiovascular Disease, together comprising over 100 faculty members investigating a wide spectrum of basic science to disease-focused and patient-based research in cardiovascular biology and disease, as well as world-class core facilities, scientific seminars and research retreats.
Comprehensive Anesthesia Research Training – University of California San Francisco
Judith Hellman, MD
Research Administration Manager
Department of Anesthesia & Perioperative Care
3333 California Street, Suite 290
San Francisco, CA 94118
Program Scope and Mission The primary goal of the program is to provide rigorous training in the fundamentals and techniques of conducting research in areas of concern to clinical anesthesiology and the larger practice of medicine. The Vascular Biology and Bioengineering Track hosts faculty mentors from the Departments of Anesthesia, Biochemistry and Biophysics, Bioengineering, Cellular and Molecular Pharmacology, Medicine, Neurosurgery, Radiology & Biomedical Imaging, and Surgery. Among the broad range of topics studied are AVMs, stroke, vascular aneurysms, drug delivery across the blood brain barrier, spinal cord injury and repair, G-protein coupled receptors, PPARs, thrombosis, novel bioengineered therapeutic antibody development and biomedical imaging. Additional program tracks include Critical Care; Genomics, Outcomes Research and Bioinformatics; and Neuroscience, Pain and Addiction. Funded by the NIH/NIGMS since 1995, the T32 program supports 2 to 3-year trainee appointments, dependent on sufficient trainee progress. Applicants should be MD or MD/PhD scientists, and must be United States citizens, permanent residents or non-citizen nationals. UCSF has an exceptional commitment to excellence and diversity. We welcome all qualified applications and particularly encourage applications from members of underrepresented groups in the sciences, including underrepresented minorities, veterans, and individuals with disabilities. UCSF offers reasonable accommodations for qualified individuals with disabilities. If you are a person with a disability who would like to discuss potential accommodations or engage in a confidential conversation, please contact Disability Management Services at 415-476-2621. Applications are accepted on a continuous basis. For more information and application instructions, contact Claire Harmon at the address above, or visit the program website.
Cardiopulmonary and Vascular Biology Research – University of Colorado Children’s Hospital
Kurt R. Stenmark, MD
Professor of Pediatrics and Medicine
Division Head, Pediatric Critical Care Medicine
Director, Developmental Lung Biology and
Cardiovascular Pulmonary Research Laboratories
Administrator, CVP Research
Program Scope and Mission The Cardiopulmonary and Vascular Biology Research Lab’s emphasis area integrates several well-established and successful programs and laboratories that utilize multidisciplinary approaches towards developing a greater understanding of basic mechanisms and therapies for the treatment of diverse cardiac, pulmonary and vascular diseases in newborns, infants and children.The overall purpose of this group is to promote basic and translational research and to develop and apply novel strategies that will enhance outcomes of children with cardiopulmonary and vascular disorders. Key goals are to facilitate and co-ordinate new program development; provide an “academic home” that will create an environment to enhance mentorship, training and career development opportunities for students, residents, fellows and faculty; establish critical core laboratories to enhance patient- and laboratory-oriented research; expand educational opportunities through integrative seminars, courses and symposia; and to more effectively link investigators from diverse disciplines to encourage further development of novel programs based on principles of “team science.” This group incorporates strengths from current programs that link clinical care, clinical research, laboratory research, education and training. Current themes of ongoing clinical and laboratory research include: basic mechanisms of angiogenesis and vascular development; the influence of vascular growth on lung structure; epigenetic mechanisms of pulmonary vascular disease; the pathobiology of pulmonary hypertension, including vascular inflammation; roles of progenitor cells in vascular development, disease and therapies; novel assessments of right ventricular function, especially in the setting of pulmonary hypertension; the epidemiology and natural history of pulmonary vascular disease in preterm infants; clinical response to drug therapy in chronic pulmonary hypertension; and the development of novel vascular therapies to promote fetal health and prevent premature birth.
Cardiovascular Biology Research - University of Hawai’i, Honolulu
Dr. Ralph Shohet
Dr. Michelle Tallquist
Center for Cardiovascular Research
John A. Burns School of Medicine
651 Ilalo Street, BSB 311
Honolulu, HI 96813
Program Scope and Mission The Training in Cardiovascular Research program is an NHLBI funded T32 grant in the Center for Cardiovascular Research at the University of Hawaii. The goal is to provide predoctoral and postdoctoral trainees with a rigorous background in cardiovascular science and techniques that will enable continued success as independent, productive, and innovative researchers. At our new medical campus on the shores of Honolulu, fellows will investigate advanced topics in cardiovascular biology within modern laboratories and with use of state-of-the-art cores. The program consists of 19 University of Hawaii investigators and an additional 10 faculty from the Cardiovascular Institute at Stanford. The training program is designed to meet individual needs but has a common core focused on a comprehensive understanding of cardiovascular science including methodology, anatomy, physiology, and molecular biology. Highlights of the program include a structured mentor program, external project review, and a cardiovascular specific curriculum including journal clubs, problem based learning, and grant writing. Appointments are 1-2 years dependent on continued progress. All fellows are encouraged to obtain independent funding, and many past trainees have been successful in procuring their own fellowships. Applications are restricted to U.S. citizens or permanent residents. For more information, please contact the Program Deputy Director at the address above.
Cardiovascular Research Training Program - University of New Mexico Health Sciences Center
Thomas C. Resta, PhD
Professor and CRTP Director
Vascular Physiology Group
Dept. of Cell Biology and Physiology
1 University of New Mexico
Albuquerque, NM 87131-0001
Home Page: http://cbp.unm.edu/faculty-profiles/resta.html
Program Scope and Mission – The Cardiovascular Research Training Program (CRTP) at the University of New Mexico (UNM) Health Sciences Center (HSC) is funded by a T32 grant from the NIH National Heart Lung and Blood Institute (NHLBI). The goal of the CRTP is to provide exceptional pre- and post-doctoral trainees a broad, multidisciplinary background in cardiovascular and pulmonary research with integration between basic and clinical sciences. The CRTP partners with the interdisciplinary Biomedical Sciences Graduate Program (BSGP; http://hsc.unm.edu/research/BREP/graduate/bsgp/index.html) at the UNM HSC. This non-departmental program provides training for PhD students in biomedical sciences in the first year followed by in-depth training in the chosen discipline in subsequent years. A training program with a concentration in cardiovascular physiology is available for all predoctoral CRTP trainees in the BSGP. The CRTP T32 provides an NIH level stipend, and allowances for tuition and fees, health insurance, training-related expenses, and travel to scientific meetings. Appointments are 2-3 years for predoctoral students and 2 years for postdoctoral trainees, with subsequent support provided by individual training fellowships or mentored career awards. Applications are restricted to U.S. citizens or permanent residents. For more information and program application instructions, please contact the CRTP Program Director, Dr. Thomas Resta, at the address below.
Bioengineering Cardiovascular Training Grant (BCTG) - University of Washington
Director and Contact:
Michael Regnier, PhD
Washington Research Foundation Professor of Bioengineering
Associate for Research, Department of Bioengineering
University of Washington
Seattle, WA 98109
Program Scope and Mission – The Bioengineering Cardiovascular Training Grant (BCTG) program provides an opportunity for predoctoral students interested in cardiovascular science and engineering to receive training support for their research under the guidance of excellent mentors. The program will simultaneously enrich the trainee’s research and strengthen the future of cardiovascular-related research and technology development in the United States.
The BCTG program is directed by Dr. Michael Regnier and a Steering Committee that selects trainees and monitors their training progress. Training support is usually provided for 2 years. Cardiovascular based research projects that involve collaboration between at least two research laboratories will be preferentially considered.
Participating departments include: Bioengineering, Biology, Chemical Engineering, Mechanical Engineering, Pathology, and Physiology & Biophysics. Predoctoral students from other departments may be considered. Students are eligible after being accepted into a laboratory and supported by the faculty mentor for at least one quarter. There are three main components of the training program:
1. Research in the laboratory of a BCTG faculty mentor on some aspect of cardiovascular physiology, pathology, development of therapeutic treatment, diagnostics and/or imaging.
2. A didactic component that includes a specialized course (Cardiac Bioengineering), a clinical cardiac imaging preceptorship, a seminar series that provides both broad-based knowledge and advanced concepts in focused areas, and a monthly journal club. Trainees with identified weaknesses in mathematics, engineering and/or integrative physiology will be strongly encouraged to do additional didactic training.
3. Communication and professional skills training by participation in seminar series, trainee seminars, and scientific writing programs. Emphasis is placed on career development, public speaking, manuscript preparation and writing fellowships or grant proposals (NIH, AHA, NSF, etc.) at the end of the training period.
Nutrition; Obesity And Atherosclerosis Training Program – University of Washington
Director and Contact:
Karin Bornfeldt, PhD
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition
Associate Director, Diabetes and Obesity Center of Excellence
Deputy Director, Diabetes Research Center
University of Washington Medicine Diabetes Institute
UW Medicine Research
850 Republican Street, Box 358055
Seattle, WA 98109-4725
Program Scope and Mission Over-nutrition and obesity are major contributors to the cardiovascular disease epidemic in the United States and worldwide. A major reason for the increase in cardiovascular disease is the increasing prevalence of obesity in both adults and children. The rationale for the T32 Nutrition, Obesity and Atherosclerosis Training Program is to train new generations of postdoctoral MD clinicians and PhD scientists to tackle these problems, taking advantage of the broad interdisciplinary environment at the University of Washington.The Nutrition, Obesity and Atherosclerosis Training Program’s overall goal is to provide a highly qualified and diverse group of postdoctoral MD clinicians and PhD scientists with the research skills they need to become fully independent biomedical investigators. The research supported by this training program centers on five themes, all related to increased risk of cardiovascular disease. The areas of focus are: i) Central obesity and its relationship to nutrition, dyslipidemia, and other cardiovascular risk factors. This theme includes both basic science and clinical studies of the mechanisms responsible for inflammation and other components of the metabolic syndrome, particularly central obesity. ii) Dyslipidemia and atherosclerosis. This theme includes studies of mechanisms, disorders, and other factors that lead to dyslipidemia, including the metabolic syndrome and diabetes. Mechanisms by which dyslipidemia influences events in the artery wall is an additional component. iii) Pathogenesis of atherosclerosis. This research investigates the pathogenesis of atherosclerosis, using isolated vascular cells and genetically engineered mice. Mouse models that overproduce or are deficient in proteins that modulate lipoprotein profiles are frequently studied. iv) Immunity in cardiovascular disease. This newly added theme studies the interrelationship among immunity, nutritional factors, obesity, and atherosclerosis both in humans and mouse models. v) Genetic and nutritional factors in cardiovascular disease. Several genetic and nutritional factors, including dietary lipids, contribute to the pathogenesis of atherosclerosis and are important in lipid disorders and inflammation. Both basic and clinical studies of the mechanisms by which genetic and nutritional factors play a role in cardiovascular disease support this theme. All of these are strong areas for both basic science and translational research emphasis at the University of Washington. In addition, each area offers our fellows numerous opportunities to acquire the multidisciplinary skills and knowledge that are essential for success in biomedical research. These areas were also chosen because they offer particularly ripe opportunities for integrating basic science and clinical medicine. This integration is essential for ensuring that today’s basic discoveries are translated into tomorrow’s clinical trials and therapies.
Your program can be listed here - click for more information